We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.86B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.42B
AUM Growth
+$205M
Cap. Flow
+$29.3M
Cap. Flow %
1.21%
Top 10 Hldgs %
31.85%
Holding
205
New
11
Increased
48
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$15.9M
2
XIFR
XPLR Infrastructure LP
XIFR
+$15.9M
3
PLTR icon
Palantir
PLTR
+$15.7M
4
QCOM icon
Qualcomm
QCOM
+$906K
5
V icon
Visa
V
+$764K

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$5.11M
2
UNP icon
Union Pacific
UNP
+$4.36M
3
UPS icon
United Parcel Service
UPS
+$3.26M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.69M
5
ADBE icon
Adobe
ADBE
+$1.47M

Sector Composition

Rank Sector Weight
1 Technology 15.55%
2 Healthcare 14.82%
3 Financials 14.35%
4 Communication Services 14.07%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APH icon
126
Amphenol
APH
$207B
$593K 0.02%
17,324
EFA icon
127
iShares MSCI EAFE ETF
EFA
$79.8B
$592K 0.02%
7,505
T icon
128
AT&T
T
$165B
$592K 0.02%
27,232
+4,041
+17% +$91.9K
LOW icon
129
Lowe's Companies
LOW
$123B
$577K 0.02%
2,976
WFC icon
130
Wells Fargo
WFC
$265B
$570K 0.02%
12,599
GLD icon
131
SPDR Gold Trust
GLD
$143B
$558K 0.02%
3,367
+50
+2% +$8.5K
WMT icon
132
Walmart Inc
WMT
$897B
$547K 0.02%
11,646
-420
-3% -$19.6K
DGX icon
133
Quest Diagnostics
DGX
$26.2B
$528K 0.02%
4,000
JPUS
134
JPMorgan Diversified Return US Equity ETF
JPUS
$464M
$523K 0.02%
+5,410
New +$518K
L icon
135
Loews
L
$23.3B
$519K 0.02%
9,502
ITOT icon
136
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$516K 0.02%
5,229
PFF icon
137
iShares Preferred and Income Securities ETF
PFF
$13.2B
$512K 0.02%
13,010
NVO
138
Novo Nordisk
NVO
$211B
$511K 0.02%
12,200
-340
-3% -$13.2K
FNF icon
139
Fidelity National Financial
FNF
$12.9B
$507K 0.02%
12,127
VWO icon
140
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$500K 0.02%
9,202
REGN icon
141
Regeneron Pharmaceuticals
REGN
$83.2B
$494K 0.02%
885
GD icon
142
General Dynamics
GD
$107B
$485K 0.02%
2,575
-85
-3% -$16K
ELME
143
Elme Communities
ELME
$143M
$443K 0.02%
19,263
AL
144
DELISTED
Air Lease Corp
AL
$438K 0.02%
10,500
SPXE icon
145
ProShares S&P 500 ex-Energy ETF
SPXE
$87.2M
$433K 0.02%
9,320
-1,260
-12% -$57K
IWO icon
146
iShares Russell 2000 Growth ETF
IWO
$14.9B
$429K 0.02%
1,376
VIG icon
147
Vanguard Dividend Appreciation ETF
VIG
$114B
$428K 0.02%
2,766
+1,368
+98% +$210K
IBB icon
148
iShares Biotechnology ETF
IBB
$9.82B
$422K 0.02%
2,580
-100
-4% -$15.4K
DVY icon
149
iShares Select Dividend ETF
DVY
$23.6B
$418K 0.02%
3,587
FXE icon
150
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$377K 0.02%
3,400

Similar funds

Klingenstein Fields & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Klingenstein Fields & Co held 205 positions worth $2.42B, up 9.3% from $2.21B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Klingenstein Fields & Co's Q2 2021 filing shows 11 new, 48 increased, 70 reduced and 7 closed positions. Its largest new stake was Eaton: 110,580 shares worth $16.4M. The largest sale was Honeywell, an estimated $5.11M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Klingenstein Fields & Co's largest Q2 2021 buy was Eaton: 110,580 shares worth $16.4M.
  • Klingenstein Fields & Co added most to Qualcomm in Q2 2021, an estimated $906K increase.
  • Klingenstein Fields & Co's biggest Q2 2021 reduction was Honeywell, cutting an estimated $5.11M.
  • Klingenstein Fields & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.05M.
  • Klingenstein Fields & Co's ten largest holdings make up 32% of its $2.42B portfolio in Q2 2021.
  • Klingenstein Fields & Co opened 11 new positions and closed 7 in Q2 2021.
  • Klingenstein Fields & Co's portfolio value rose 9.3% quarter-over-quarter to $2.42B.

Based on Klingenstein Fields & Co's 13F filing for Q2 2021, filed 26 Jul 2021.